Travere Therapeutics, Inc.
TVTX
$42.84
-$0.67-1.54%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
Business Wire
5/12/2026
-
MarketBeat
5/10/2026
-
Fool.com Headlines
5/9/2026
-
MarketBeat
5/9/2026
-
The Cerbat Gem
5/9/2026
-
MarketBeat
5/9/2026
-
MarketBeat
5/9/2026
-
MarketBeat
5/7/2026
-
Business Wire
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
5/7/2026
-
The Cerbat Gem
5/7/2026
-
MarketBeat
5/7/2026
-
The Cerbat Gem
5/7/2026
-
Business Wire
5/7/2026
-
MarketBeat
5/7/2026
-
MarketBeat
5/7/2026
-
The Cerbat Gem
5/7/2026
-
The Cerbat Gem
5/7/2026
-
MarketBeat
5/7/2026
-
MarketBeat
5/7/2026
-
MarketBeat
5/7/2026
-
MarketBeat
5/7/2026
-
MarketBeat
5/7/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 4, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
888 969 7879
Address
3611 Valley Centre Drive
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
--
Business Description
Sector
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company’s...
more